ON-013100
new
featured

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 406838

CAS#: 865783-95-5

Description: ON-013100 is a cell cycle inhibitor and is potentially useful for the treatment of mantle cell lymphoma.


Price and Availability

Size Price Shipping out time Quantity
1g USD 3450 2 Weeks
2g USD 5750 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2020-10-22. Prices are subject to change without notice.

ON-013100, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 406838
Name: ON-013100
CAS#: 865783-95-5
Chemical Formula: C19H22O7S
Exact Mass: 394.1086
Molecular Weight: 394.438
Elemental Analysis: C, 57.86; H, 5.62; O, 28.39; S, 8.13


Synonym: ON-013100; ON 013100; ON013100.

IUPAC/Chemical Name: (E)-5-(((2,4,6-Trimethoxystyryl)sulfonyl)methyl)-2-methoxyphenol

InChi Key: GHPUSRLWNSTQIK-BQYQJAHWSA-N

InChi Code: InChI=1S/C19H22O7S/c1-23-14-10-18(25-3)15(19(11-14)26-4)7-8-27(21,22)12-13-5-6-17(24-2)16(20)9-13/h5-11,20H,12H2,1-4H3/b8-7+

SMILES Code: OC1=CC(CS(=O)(/C=C/C2=C(OC)C=C(OC)C=C2OC)=O)=CC=C1OC


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Cho SY, Cosenza SC, Pallela V, Panda G, Reddy MV, Reddy EP, Roboz J.
Determination of the glucuronide metabolite of ON 013100, a benzylstyrylsulfone
antineoplastic drug, in colon cancer cells using LC/MS/MS. J Pharm Biomed Anal.
2013 Mar 5;75:138-44. doi: 10.1016/j.jpba.2012.11.022. Epub 2012 Nov 23. PubMed
PMID: 23261806.

2: Nuthalapati S, Zhou Q, Guo P, Lv H, Cosenza S, Reddy MV, Reddy EP, Gallo JM.
Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer
agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor
chemotherapy. Pharm Res. 2012 Sep;29(9):2499-511. doi: 10.1007/s11095-012-0780-y.
Epub 2012 Jun 8. PubMed PMID: 22678771.

3: Park IW, Reddy MV, Reddy EP, Groopman JE. Evaluation of novel cell cycle
inhibitors in mantle cell lymphoma. Oncogene. 2007 Aug 16;26(38):5635-42. Epub
2007 Mar 19. PubMed PMID: 17369860.